GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Merck & Co Inc (BUE:MRK) » Definitions » Shiller PE Ratio

Merck (BUE:MRK) Shiller PE Ratio : 41.74 (As of May. 26, 2024)


View and export this data going back to . Start your Free Trial

What is Merck Shiller PE Ratio?

As of today (2024-05-26), Merck's current share price is ARS32045.00. Merck's E10 for the quarter that ended in Mar. 2024 was ARS767.65. Merck's Shiller PE Ratio for today is 41.74.

The historical rank and industry rank for Merck's Shiller PE Ratio or its related term are showing as below:

BUE:MRK' s Shiller PE Ratio Range Over the Past 10 Years
Min: 17.86   Med: 26.91   Max: 39.37
Current: 36.58

During the past years, Merck's highest Shiller PE Ratio was 39.37. The lowest was 17.86. And the median was 26.91.

BUE:MRK's Shiller PE Ratio is ranked worse than
70.47% of 535 companies
in the Drug Manufacturers industry
Industry Median: 24.25 vs BUE:MRK: 36.58

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Merck's adjusted earnings per share data for the three months ended in Mar. 2024 was ARS15,754.750. Add all the adjusted EPS for the past 10 years together and divide 10 will get our E10, which is ARS767.65 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Merck Shiller PE Ratio Historical Data

The historical data trend for Merck's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Merck Shiller PE Ratio Chart

Merck Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 39.15 31.30 26.05 32.35 32.38

Merck Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 30.13 35.01 29.75 32.38 37.28

Competitive Comparison of Merck's Shiller PE Ratio

For the Drug Manufacturers - General subindustry, Merck's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Merck's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Merck's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Merck's Shiller PE Ratio falls into.



Merck Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Merck's Shiller PE Ratio for today is calculated as

Shiller PE Ratio=Share Price/ E10
=32045.00/767.65
=41.74

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Merck's E10 for the quarter that ended in Mar. 2024 is calculated as:

For example, Merck's adjusted earnings per share data for the three months ended in Mar. 2024 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=15754.75/131.7762*131.7762
=15,754.750

Current CPI (Mar. 2024) = 131.7762.

Merck Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201406 55.250 100.560 72.401
201409 26.099 100.428 34.246
201412 217.195 99.070 288.899
201503 29.105 99.621 38.499
201506 21.808 100.684 28.543
201509 60.175 100.392 78.987
201512 45.300 99.792 59.819
201603 58.416 100.470 76.618
201606 60.113 101.688 77.900
201609 116.351 101.861 150.522
201612 66.580 101.863 86.132
201703 86.335 102.862 110.603
201706 117.065 103.349 149.265
201709 -3.505 104.136 -4.435
201712 -61.747 104.011 -78.230
201803 54.402 105.290 68.087
201806 157.122 106.317 194.748
201809 268.633 106.507 332.368
201812 260.165 105.998 323.436
201903 437.808 107.251 537.925
201906 460.194 108.070 561.145
201909 413.852 108.329 503.426
201912 549.917 108.420 668.381
202003 782.073 108.902 946.347
202006 807.828 108.767 978.718
202009 861.184 109.815 1,033.408
202012 -675.454 109.897 -809.930
202103 1,126.000 111.754 1,327.733
202106 577.853 114.631 664.279
202109 1,760.040 115.734 2,003.999
202112 1,494.652 117.630 1,674.406
202203 1,825.325 121.301 1,982.955
202206 1,865.115 125.017 1,965.958
202209 1,778.560 125.227 1,871.584
202212 1,978.270 125.222 2,081.817
202303 2,192.805 127.348 2,269.058
202306 -5,640.000 128.729 -5,773.520
202309 6,509.070 129.860 6,605.143
202312 -1,732.800 129.419 -1,764.355
202403 15,754.750 131.776 15,754.750

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Merck  (BUE:MRK) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Merck Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Merck's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Merck (BUE:MRK) Business Description

Address
126 East Lincoln Avenue, Rahway, NJ, USA, 07065
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent pediatric diseases as well as human papillomavirus, or HPV. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the company's sales are generated in the United States.